{"id":77629,"date":"2025-12-03T08:54:52","date_gmt":"2025-12-03T07:54:52","guid":{"rendered":"https:\/\/www.embl.org\/news\/?post_type=awards&#038;p=77629"},"modified":"2025-12-03T08:54:52","modified_gmt":"2025-12-03T07:54:52","slug":"sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease","status":"publish","type":"awards","link":"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease","title":{"rendered":"Sagar Bhogaraju receives prestigious grant to study ubiquitin signalling in health and disease"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.embl.org\/people\/person\/bhogaraju\/\">Sagar Bhogaraju<\/a>, a group leader at EMBL Grenoble, has been awarded the <a href=\"https:\/\/www.fondationbs.org\/en\/what-we-do\/life-sciences\/impulscience\">Impulscience\u00ae grant<\/a> by the Fondation Bettencourt Schueller for his work on ubiquitin signalling in disease and physiology. This prize comes with \u20ac2.3M of grant money, which will support Bhogaraju and his team as they investigate novel cell signalling mechanisms involved in diseases such as cancer.<\/p>\n\n\n\n<p>The Bhogaraju Group studies ubiquitin signalling mediated by a specific class of human proteins known as Melanoma antigens (MAGEs). Most MAGE genes are only expressed in the testis in healthy individuals but are aberrantly overexpressed in different cancers, making them a strong indicator of diseased states. Scientists use structural biology, cell biology, and proteomics-based methods to understand how MAGEs mediate their cancer-promoting signalling. Surprisingly, some MAGE proteins also participate in neuronal signalling and play important roles in normal animal behaviour. All MAGE proteins interact with a class of enzymes known as ubiquitin ligases to form MAGE-RING ligases.<\/p>\n\n\n\n<p>Members of the Bhogaraju<a href=\"https:\/\/doi.org\/10.1126\/sciadv.adp3000\"> Group have recently developed a proteomics-based method known as Ub-POD that allows mapping of substrates of ubiquitin ligases at scale<\/a>. The Impulscience\u00ae grant will allow the team to employ this technology on MRLs to map their targets in cancer cells. This work will lay the groundwork to understand the fundamental biology of MAGE protein signalling and can uncover novel therapeutic targets. The grant will also allow the group to further develop the Ub-POD method and its applications.<\/p>\n\n\n\n<p>\u201cIt is a great honour to receive this award. I thank the Fondation Bettencourt Schueller for this amazing support to our research. This will strengthen our team and will enable us to tackle this understudied family of human ubiquitin ligases, which have amazing therapeutic potential,\u201d said Bhogaraju. \u201cBut in order to leverage their potential, we first have to understand what precisely is their role in human diseases.\u201d<\/p>\n\n\n\n<figure class=\"vf-figure wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" class=\"vf-figure__image\" src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/12\/image-1024x683.jpeg\" alt=\"\" class=\"wp-image-77633\" srcset=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/12\/image-1024x683.jpeg 1024w, https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/12\/image-300x200.jpeg 300w, https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/12\/image-768x512.jpeg 768w, https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/12\/image.jpeg 1600w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"vf-figure__caption\">Group photo of the Bhogaraju research group, from the left to the right: Anna-Mariya Anastasova, Hannah Murillo, Sagar Bhogaraju, Lucas Wilson, Teresa Carusone, Sarah Gharb and Vinay Dayaratna.\u00a0 Credit: Alexandre Darmon\/ Art in Research for the Fondation Bettencourt Schueller<\/figcaption><\/figure>\n\n\n\n<p>For this reason, the seven researchers in the 2025 Impulscience\u00ae cohort embody the momentum of innovation tackling today\u2019s major challenges. Their interdisciplinary work will deepen knowledge of women\u2019s health, cancer, and brain function through evolutionary biology.<\/p>\n\n\n\n\n","protected":false},"excerpt":{"rendered":"<p>The \u20ac2.3 million Impulscience\u00ae grant will enable the EMBL Grenoble team to advance research on ubiquitin signalling, cancer mechanisms, and therapeutic targets.<\/p>\n","protected":false},"author":179,"featured_media":77651,"parent":0,"menu_order":0,"template":"","tags":[149,789,38,64,525,37,35],"award-type":[17599],"award-unit":[17651],"award-site":[17603],"class_list":["post-77629","awards","type-awards","status-publish","has-post-thumbnail","hentry","tag-award","tag-bhogaraju","tag-cancer","tag-cell-biology","tag-cell-signalling","tag-grenoble","tag-structural-biology","award-type-award","award-unit-structural-biology-gr","award-site-grenoble"],"acf":{"vf-news-ah-unit":[17651],"vf-news-ah-type":[17599],"vf-news-ah-site":[17603]},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>EMBL | Sagar Bhogaraju receives prestigious grant to study ubiquitin signalling in health and disease<\/title>\n<meta name=\"description\" content=\"Sagar Bhogaraju receives prestigious grant to study ubiquitin signalling in health and disease\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EMBL | Sagar Bhogaraju receives prestigious grant to study ubiquitin signalling in health and disease\" \/>\n<meta property=\"og:description\" content=\"Sagar Bhogaraju receives prestigious grant to study ubiquitin signalling in health and disease\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/12\/20240419_Awards_Honours_Template3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/\",\"url\":\"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/\",\"name\":\"EMBL | Sagar Bhogaraju receives prestigious grant to study ubiquitin signalling in health and disease\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/12\/20240419_Awards_Honours_Template3.jpg\",\"datePublished\":\"2025-12-03T07:54:52+00:00\",\"description\":\"Sagar Bhogaraju receives prestigious grant to study ubiquitin signalling in health and disease\",\"breadcrumb\":{\"@id\":\"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/#primaryimage\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/12\/20240419_Awards_Honours_Template3.jpg\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/12\/20240419_Awards_Honours_Template3.jpg\",\"width\":1000,\"height\":600,\"caption\":\"Picture of Sagar Bhogaraju, 2025 laureate of the Bettencourt Schueller Impulscience\u00ae award.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Awards & Honours\",\"item\":\"https:\/\/www.embl.org\/news\/awards-honours\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sagar Bhogaraju receives prestigious grant to study ubiquitin signalling in health and disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.embl.org\/news\/#website\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.embl.org\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.embl.org\/news\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/embl.org\/\",\"https:\/\/x.com\/embl\",\"https:\/\/www.instagram.com\/embl_org\/\",\"https:\/\/www.linkedin.com\/company\/15813\/\",\"https:\/\/www.youtube.com\/user\/emblmedia\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EMBL | Sagar Bhogaraju receives prestigious grant to study ubiquitin signalling in health and disease","description":"Sagar Bhogaraju receives prestigious grant to study ubiquitin signalling in health and disease","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/","og_locale":"en_US","og_type":"article","og_title":"EMBL | Sagar Bhogaraju receives prestigious grant to study ubiquitin signalling in health and disease","og_description":"Sagar Bhogaraju receives prestigious grant to study ubiquitin signalling in health and disease","og_url":"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","og_image":[{"width":1000,"height":600,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/12\/20240419_Awards_Honours_Template3.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@embl","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/","url":"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/","name":"EMBL | Sagar Bhogaraju receives prestigious grant to study ubiquitin signalling in health and disease","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/#primaryimage"},"image":{"@id":"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/12\/20240419_Awards_Honours_Template3.jpg","datePublished":"2025-12-03T07:54:52+00:00","description":"Sagar Bhogaraju receives prestigious grant to study ubiquitin signalling in health and disease","breadcrumb":{"@id":"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/#primaryimage","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/12\/20240419_Awards_Honours_Template3.jpg","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/12\/20240419_Awards_Honours_Template3.jpg","width":1000,"height":600,"caption":"Picture of Sagar Bhogaraju, 2025 laureate of the Bettencourt Schueller Impulscience\u00ae award."},{"@type":"BreadcrumbList","@id":"https:\/\/www.embl.org\/news\/awards-honours\/sagar-bhogaraju-receives-prestigious-grant-to-study-ubiquitin-signalling-in-health-and-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Awards & Honours","item":"https:\/\/www.embl.org\/news\/awards-honours\/"},{"@type":"ListItem","position":2,"name":"Sagar Bhogaraju receives prestigious grant to study ubiquitin signalling in health and disease"}]},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/awards\/77629","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/awards"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/awards"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/users\/179"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media\/77651"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=77629"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/tags?post=77629"},{"taxonomy":"award-type","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/award-type?post=77629"},{"taxonomy":"award-unit","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/award-unit?post=77629"},{"taxonomy":"award-site","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/award-site?post=77629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}